163 related articles for article (PubMed ID: 22116208)
1. Peripheral chondrosarcoma progression is associated with increased type X collagen and vascularisation.
de Andrea CE; Wiweger MI; Bovée JV; Romeo S; Hogendoorn PC
Virchows Arch; 2012 Jan; 460(1):95-102. PubMed ID: 22116208
[TBL] [Abstract][Full Text] [Related]
2. Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT.
de Andrea CE; Reijnders CM; Kroon HM; de Jong D; Hogendoorn PC; Szuhai K; Bovée JV
Oncogene; 2012 Mar; 31(9):1095-104. PubMed ID: 21804604
[TBL] [Abstract][Full Text] [Related]
3. Epiphyseal growth plate and secondary peripheral chondrosarcoma: the neighbours matter.
de Andrea CE; Hogendoorn PC
J Pathol; 2012 Jan; 226(2):219-28. PubMed ID: 21956842
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma.
Bovée JV; van den Broek LJ; Cleton-Jansen AM; Hogendoorn PC
Lab Invest; 2000 Dec; 80(12):1925-34. PubMed ID: 11140704
[TBL] [Abstract][Full Text] [Related]
5. EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas.
Bovée JV; Cleton-Jansen AM; Wuyts W; Caethoven G; Taminiau AH; Bakker E; Van Hul W; Cornelisse CJ; Hogendoorn PC
Am J Hum Genet; 1999 Sep; 65(3):689-98. PubMed ID: 10441575
[TBL] [Abstract][Full Text] [Related]
6. Decreased EXT expression and intracellular accumulation of heparan sulphate proteoglycan in osteochondromas and peripheral chondrosarcomas.
Hameetman L; David G; Yavas A; White SJ; Taminiau AH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV
J Pathol; 2007 Mar; 211(4):399-409. PubMed ID: 17226760
[TBL] [Abstract][Full Text] [Related]
7. Structural Features of Heparan Sulfate from Multiple Osteochondromas and Chondrosarcomas.
Veraldi N; Parra A; Urso E; Cosentino C; Locatelli M; Corsini S; Pedrini E; Naggi A; Bisio A; Sangiorgi L
Molecules; 2018 Dec; 23(12):. PubMed ID: 30544937
[TBL] [Abstract][Full Text] [Related]
8. Methylation status of EXT1 and EXT2 promoters and two mutations of EXT2 in chondrosarcoma.
Tsuchiya T; Osanai T; Ogose A; Tamura G; Chano T; Kaneko Y; Ishikawa A; Orui H; Wada T; Ikeda T; Namba M; Takigawa M; Kawashima H; Hotta T; Tsuchiya A; Ogino T; Motoyama T
Cancer Genet Cytogenet; 2005 Apr; 158(2):148-55. PubMed ID: 15796962
[TBL] [Abstract][Full Text] [Related]
9. Somatic loss of an EXT2 gene mutation during malignant progression in a patient with hereditary multiple osteochondromas.
Musso N; Caronia FP; Castorina S; Lo Monte AI; Barresi V; Condorelli DF
Cancer Genet; 2015 Mar; 208(3):62-7. PubMed ID: 25744876
[TBL] [Abstract][Full Text] [Related]
10. Gli2 and p53 cooperate to regulate IGFBP-3- mediated chondrocyte apoptosis in the progression from benign to malignant cartilage tumors.
Ho L; Stojanovski A; Whetstone H; Wei QX; Mau E; Wunder JS; Alman B
Cancer Cell; 2009 Aug; 16(2):126-36. PubMed ID: 19647223
[TBL] [Abstract][Full Text] [Related]
11. Signaling systems affecting the severity of multiple osteochondromas.
Piombo V; Jochmann K; Hoffmann D; Wuelling M; Vortkamp A
Bone; 2018 Jun; 111():71-81. PubMed ID: 29545125
[TBL] [Abstract][Full Text] [Related]
12. Aberrant heparan sulfate proteoglycan localization, despite normal exostosin, in central chondrosarcoma.
Schrage YM; Hameetman L; Szuhai K; Cleton-Jansen AM; Taminiau AH; Hogendoorn PC; Bovée JV
Am J Pathol; 2009 Mar; 174(3):979-88. PubMed ID: 19179614
[TBL] [Abstract][Full Text] [Related]
13. Osteochondromas: review of the clinical, radiological and pathological features.
Kitsoulis P; Galani V; Stefanaki K; Paraskevas G; Karatzias G; Agnantis NJ; Bai M
In Vivo; 2008; 22(5):633-46. PubMed ID: 18853760
[TBL] [Abstract][Full Text] [Related]
14. Multiple osteochondromas.
Bovée JV
Orphanet J Rare Dis; 2008 Feb; 3():3. PubMed ID: 18271966
[TBL] [Abstract][Full Text] [Related]
15. Type X collagen expression and hypertrophic differentiation in chondrogenic neoplasias.
Aigner T; Frischholz S; Dertinger S; Beier F; Girkontaité I; von der Mark K
Histochem Cell Biol; 1997 Jun; 107(6):435-40. PubMed ID: 9243276
[TBL] [Abstract][Full Text] [Related]
16. Primary cilia organization reflects polarity in the growth plate and implies loss of polarity and mosaicism in osteochondroma.
de Andrea CE; Wiweger M; Prins F; Bovée JV; Romeo S; Hogendoorn PC
Lab Invest; 2010 Jul; 90(7):1091-101. PubMed ID: 20421870
[TBL] [Abstract][Full Text] [Related]
17. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Rushing EJ
Hum Pathol; 2010 May; 41(5):653-62. PubMed ID: 20138330
[TBL] [Abstract][Full Text] [Related]
18. Genetic models of osteochondroma onset and neoplastic progression: evidence for mechanisms alternative to EXT genes inactivation.
Zuntini M; Pedrini E; Parra A; Sgariglia F; Gentile FV; Pandolfi M; Alberghini M; Sangiorgi L
Oncogene; 2010 Jul; 29(26):3827-34. PubMed ID: 20418910
[TBL] [Abstract][Full Text] [Related]
19. Ext-mutation analysis in Italian sporadic and hereditary osteochondromas.
Gigante M; Matera MG; Seripa D; Izzo AM; Venanzi R; Giannotti A; Digilio MC; Gravina C; Lazzari M; Monteleone G; Monteleone M; Dallapiccola B; Fazio VM
Int J Cancer; 2001 Nov; 95(6):378-83. PubMed ID: 11668521
[TBL] [Abstract][Full Text] [Related]
20. Dysplasia epiphysealis hemimelica (Trevor disease): a rare developmental disorder of bone mimicking osteochondroma of long bones.
Glick R; Khaldi L; Ptaszynski K; Steiner GC
Hum Pathol; 2007 Aug; 38(8):1265-72. PubMed ID: 17490719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
